These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 2408906

  • 1. The effects of amiflamine on cerebrospinal fluid amine metabolites in the rhesus monkey.
    Garrick NA, Seppala T, Linnoila M, Murphy DL.
    Eur J Pharmacol; 1985 Mar 26; 110(1):1-9. PubMed ID: 2408906
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of clorgyline on catecholamine and indoleamine metabolites in the cerebrospinal fluid of rhesus monkeys.
    Garrick NA, Scheinin M, Chang WH, Linnoila M, Murphy DL.
    Biochem Pharmacol; 1984 May 01; 33(9):1423-7. PubMed ID: 6203542
    [Abstract] [Full Text] [Related]

  • 3. Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone.
    Garrick NA, Seppala T, Linnoila M, Murphy DL.
    Psychopharmacology (Berl); 1985 May 01; 86(3):265-9. PubMed ID: 2412251
    [Abstract] [Full Text] [Related]

  • 4. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M.
    Med Biol; 1985 May 01; 63(1):1-17. PubMed ID: 2582215
    [Abstract] [Full Text] [Related]

  • 5. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD, Sourkes TL, Fang TY, Young SN, Gauthier SG, Missala K.
    Neurology; 1979 Aug 01; 29(8):1157-61. PubMed ID: 37460
    [Abstract] [Full Text] [Related]

  • 6. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ, Scheinin M, Golden RN, Rudorfer MV, Cowdry RW, Calil HM, Ross RJ, Linnoila M.
    Arch Gen Psychiatry; 1985 Dec 01; 42(12):1171-7. PubMed ID: 2416297
    [Abstract] [Full Text] [Related]

  • 7. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ, Bird ED, McEntee WJ.
    Ann Neurol; 1982 Jul 01; 12(1):48-51. PubMed ID: 6180677
    [Abstract] [Full Text] [Related]

  • 8. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM, Sims NR, Bowen DM, Neary D, Palo J, Wikstrom J, Davison AN.
    J Neurol Neurosurg Psychiatry; 1984 May 01; 47(5):481-4. PubMed ID: 6204017
    [Abstract] [Full Text] [Related]

  • 9. Amine metabolites in ventricular cerebrospinal fluid in coma.
    Yates CM, Tsementzis SA, Wilson H.
    J Neurol Neurosurg Psychiatry; 1979 Oct 01; 42(10):887-91. PubMed ID: 512664
    [Abstract] [Full Text] [Related]

  • 10. Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat.
    Ask AL, Fagervall I, Jonze M, Kelder D, Nygren R, Ross SB.
    Biochem Pharmacol; 1984 Sep 15; 33(18):2839-47. PubMed ID: 6477643
    [Abstract] [Full Text] [Related]

  • 11. CSF monoamine metabolites in mania.
    Swann AC, Secunda S, Davis JM, Robins E, Hanin I, Koslow SH, Maas JW.
    Am J Psychiatry; 1983 Apr 15; 140(4):396-400. PubMed ID: 6188381
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased total activity in the rat after L-tryptophan plus the monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgyline.
    Archer T, Fowler CJ, Fredriksson A, Lewander T, Magnusson O, Mohringe B, Söderberg U.
    Br J Pharmacol; 1985 Jul 15; 85(3):581-90. PubMed ID: 2411326
    [Abstract] [Full Text] [Related]

  • 14. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul 15; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]

  • 15. Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.
    Sunderland T, Tariot PN, Cohen RM, Newhouse PA, Mellow AM, Mueller EA, Murphy DL.
    Psychopharmacology (Berl); 1987 Jul 15; 91(3):293-6. PubMed ID: 2436247
    [Abstract] [Full Text] [Related]

  • 16. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.
    Roy A, Ninan P, Mazonson A, Pickar D, Van Kammen D, Linnoila M, Paul SM.
    Psychol Med; 1985 May 15; 15(2):335-40. PubMed ID: 2410941
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.
    Biol Psychiatry; 1983 Oct 15; 18(10):1141-52. PubMed ID: 6197099
    [Abstract] [Full Text] [Related]

  • 18. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF, Waldmeier P, Beckmann H.
    Acta Psychiatr Scand; 1982 Nov 15; 66(5):350-60. PubMed ID: 6184954
    [Abstract] [Full Text] [Related]

  • 19. Aggression in humans correlates with cerebrospinal fluid amine metabolites.
    Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF.
    Psychiatry Res; 1979 Oct 15; 1(2):131-9. PubMed ID: 95232
    [Abstract] [Full Text] [Related]

  • 20. Minipump clorgyline administration and CSF amine metabolites in unrestrained monkeys.
    Cox M, Garrick N, Reite M, Gennaro M.
    Pharmacol Biochem Behav; 1991 Mar 15; 38(3):677-9. PubMed ID: 1712497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.